People Briefs
This article was originally published in The Gray Sheet
Executive Summary
NuVasive appoints executive VP, general counsel; Danaher names senior VP and general counsel; and genomic informatics company Human Longevity acquires Cypher Genomics, and in the process names Cypher CEO Ashley Van Zeeland as head of the firm's pediatric business.
You may also be interested in...
Business Briefs
Hill-Rom's acquisition of Welch Allyn speeds ahead; Nuvasive builds its team; Philips divests pediatric respiratory products.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.